Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
about
A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responsesIn vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cellsThe qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremiaStrong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1betaSelection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infectionPositive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infectionThe hope for an HIV vaccine based on induction of CD8+ T lymphocytes--a reviewTelomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytesPotent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccinationNatural host genetic resistance to lentiviral CNS disease: a neuroprotective MHC class I allele in SIV-infected macaquesT helper cell activation and human retroviral pathogenesisTargeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunizationDurable cytotoxic immune responses against gp120 elicited by recombinant SV40 vectors encoding HIV-1 gp120 +/- IL-15CD8+ T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjectsDifferences in time of virus appearance in the blood and virus-specific immune responses in intravenous and intrarectal primary SIVmac251 infection of rhesus macaques; a pilot studyContrasting Adult and Infant Immune Responses to HIV Infection and VaccinationChallenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsEnhancing Human Immunodeficiency Virus-Specific CD8(+) T Cell Responses with Heteroclitic PeptidesVaccination-induced noncytolytic effects in the acute phase of SHIV infectionSelective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispeciesBiologically-directed modeling reflects cytolytic clearance of SIV-infected cells in vivo in macaquesImmunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletionsEx vivo SIV-specific CD8 T cell responses in heterozygous animals are primarily directed against peptides presented by a single MHC haplotypeGagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivoImpaired antibody response causes persistence of prototypic T cell-contained virusViral CTL escape mutants are generated in lymph nodes and subsequently become fixed in plasma and rectal mucosa during acute SIV infection of macaquesSang Froid in a time of trouble: is a vaccine against HIV possible?Distinct HIV-1 Escape Patterns Selected by Cytotoxic T Cells with Identical Epitope SpecificityInnate and Adaptive Immune Regulation During Chronic Viral InfectionsEngineering T Cells to Functionally Cure HIV-1 InfectionAnalysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivoStrong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removalHLA-driven convergence of HIV-1 viral subtypes B and F toward the adaptation to immune responses in human populationsInfluence of HAART on alternative reading frame immune responses over the course of HIV-1 infectionHIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscapeMeasurements of immune responses for establishing correlates of vaccine protection against HIVCross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapyIncreased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequencesLong-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine
P2860
Q21135240-812A2AC8-C064-420E-9669-4A2B6668073BQ21559398-4B53AD86-8C07-409D-8007-1430D47BF631Q22248074-F57ECE49-8649-4672-AEB0-016C8F7AE8C9Q24516944-22A76861-CCDF-4FAB-B3AE-E94675B6B8CBQ24555821-D94EAE48-D3CC-4F97-A5E0-BFDD306F6BCCQ24564623-F91FB4F9-C237-48E6-A024-691B7410500CQ24564779-F57AE74B-D65A-4BD0-B589-83071799C0D4Q24630490-4DC0B83E-1130-4FDA-892F-BE80D252D46AQ24644212-6119DB59-F33B-4F2A-881D-54B8A70E1EA5Q24646818-261E3A12-5ABA-4401-9362-44DBF5D727EEQ24647731-4452D145-EC08-40B8-B7D4-D78816F12BF2Q24650854-8BD04D9D-C000-40EB-83E8-6DCEF3F5E79AQ24670153-5729216C-A8B6-4C55-9AED-8E21A6E2EAE5Q24792056-98E99F82-F178-4119-9E85-73459EA9EE59Q24798701-9F2F378D-9907-4406-83FF-BF7B51E9063AQ24802232-F22E8B02-ECD8-4181-896B-B2B1351B96CAQ26776518-50DA5A00-5FFD-4B67-86D4-1E83FEC0E51DQ26781511-2CD8B9EE-6229-446B-99B5-915A1925E41EQ26800123-4824AE54-F3D6-4DB2-A5F1-14E02A1CB15AQ27313589-B0FF244C-446B-483D-80D6-6B263462EE9AQ27318192-42AC8156-056B-4BD6-BA5E-BE724394ACBEQ27319762-1B8143CB-A2E5-41B8-9FCE-9FED2149FD2BQ27320923-5AE6F8AF-F515-4858-8DA0-8311E48E0BE2Q27322650-1F217FAF-DE9D-4C6F-8170-68EA2538A88BQ27324128-C2C4B506-1EE7-4F7D-88BD-5E23CD1A52DEQ27331309-E369300E-229F-47AB-B48A-DA85374B283DQ27349889-C807CDCC-F83F-4110-A99B-FE40A497670EQ27487961-2D39F27E-D901-4D88-A4EB-9362B7083025Q27675464-1A37B030-076F-4EAC-8310-79B9EEDDE4B8Q28079717-2709927B-DE51-4164-8712-07CC8B0C11F7Q28086801-DCC73BE2-CD5C-4472-B407-732DC72FFB07Q28379312-85FD07D1-00D6-4A15-BB4B-7BB06B3B97F7Q28469094-70620BA1-C68F-49FA-A575-32AA6F43238EQ28473841-B1123EB0-44A9-468C-A8E0-2AEC6A3D5702Q28480902-D7415CAF-456B-4C69-A073-FE0DD4A1B05EQ28487168-2D43E3BF-C6CA-4FF8-B019-12D8D5417304Q28728189-5F221B4E-59D7-4307-82B5-D14DB3664F8DQ28740329-E88BAF2D-E7ED-4CCE-AEC6-AEEAB5DEE46CQ28741616-630CDF16-93EE-4903-87E3-9D476CC2CEE5Q28743435-121B0C2A-65BE-4CC8-B7A4-A856105EEC36
P2860
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Virus-specific CD8+ cytotoxic ...... iciency virus type 1 infection
@ast
Virus-specific CD8+ cytotoxic ...... iciency virus type 1 infection
@en
Virus-specific CD8+ cytotoxic ...... iciency virus type 1 infection
@nl
type
label
Virus-specific CD8+ cytotoxic ...... iciency virus type 1 infection
@ast
Virus-specific CD8+ cytotoxic ...... iciency virus type 1 infection
@en
Virus-specific CD8+ cytotoxic ...... iciency virus type 1 infection
@nl
prefLabel
Virus-specific CD8+ cytotoxic ...... iciency virus type 1 infection
@ast
Virus-specific CD8+ cytotoxic ...... iciency virus type 1 infection
@en
Virus-specific CD8+ cytotoxic ...... iciency virus type 1 infection
@nl
P2093
P2860
P921
P3181
P1433
P1476
Virus-specific CD8+ cytotoxic ...... iciency virus type 1 infection
@en
P2093
P2860
P304
P3181
P407
P577
1994-09-01T00:00:00Z